Advertisement

What Are the Acute and Long-Term Results of Transvenous Implantable Cardioverter Defibrillators?

  • G. Gasparini
  • A. Raviele
  • S. Themistoclakis
  • Italian Endotak Investigator Group
Conference paper

Abstract

The clinical experience with implantable cardioverter defibrillators (ICD) has been limited for many years almost exclusively to devices requiring thoracotomy for placement of one or more epicardial electrodes. This has generated a significant perioperative mortality and morbidity (1,2) and has reduced the widespread clinical application of such a therapy. In the last few years, different transvenous systems have been developed and introduced into clinical practice (3–12). One of these systems (Endotak, CPI, St Paul, MN, USA) has been extensively evaluated in Italy since 1990 by means of a multicenter trial (37 centers). In this paper the results of this trial are reported.

Keywords

Implantable Cardioverter Defibrillator Implantable Cardioverter Defibrillator Therapy Implantable Cardioverter Defibrillator Implantation Inappropriate Shock Defibrillation Threshold 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mosteller RD, Lehman MH, Thomas AC, Jackson K and Participating Investigators (1991) Operative mortality with implantation of the automatic cardioverter-defibrillator. Am J Cardiol 68: 1340–1345PubMedCrossRefGoogle Scholar
  2. 2.
    Grimm W, Flores BF, Marchlinski FE (1993) Complications of implantable cardioverter defibrillator therapy: follow-up of 241 patients. PACE 16: 218–222PubMedCrossRefGoogle Scholar
  3. 3.
    Saksena S, Parsonnet V (1988) Implantation of a cardioverterdefibrillator without thoracotomy using a triple electrode system. JAMA 259: 69–72PubMedCrossRefGoogle Scholar
  4. 4.
    Tullo NG, Saksena S, Krol KB, Mauro AM, Kunecz D (1990) Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverter-defibrillators. Am J Cardiol 66: 411–415PubMedCrossRefGoogle Scholar
  5. 5.
    McCowan R, Maloney J, Wilkoff B et al (1991) Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscolar patch system. J Am Coll Cardiol 17: 415–421PubMedCrossRefGoogle Scholar
  6. 6.
    Hauser RG, Kurschinski DT, McVeigh K, Thomas A, Mower MM (1993) Clinical results with nonthoracotomy ICD system. PACE 16: 141–152PubMedCrossRefGoogle Scholar
  7. 7.
    Neuzner J for the European Ventak P2 Investigator Group (1994) Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. PACE 17: 1243–1255CrossRefGoogle Scholar
  8. 8.
    Bardy GH, Hofer B, Johnson G (1993) Implantable transvenous cardioverter-defibrillators. Circulation 87: 1152–1168PubMedGoogle Scholar
  9. 9.
    Saksena S for the PCD Investigator Group (1994) Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator with and without thoracotomy: an international multicenter study. J Am Coll Cardiol 23: 1521–1530CrossRefGoogle Scholar
  10. 10.
    Bardy GH, Johnson G, Poole JE et al (1993) A simplified, single lead unipolar transvenous cardioversion-defibrillation system. Circulation 88: 543–547PubMedGoogle Scholar
  11. 11.
    Sra JS, Natale A, Axtell K et al (1994) Experience with two different nonthoracotomy system for implantable defibrillator in 170 patients. PACE 17: 1741–1750PubMedCrossRefGoogle Scholar
  12. 12.
    Brachmann J, Sterns LD, Hilbel T et al (1994) Acute efficacy and chronic follow-up with non-thoracotomy third generation implantable defibrillators. PACE 17: 499–505PubMedCrossRefGoogle Scholar
  13. 13.
    Jordaens L, Vertongen P, Van Belleghem Y (1993) A subcutaneous lead array for implantable cardioverter defibrillators. PACE 16: 1429–1433PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1996

Authors and Affiliations

  • G. Gasparini
    • 1
  • A. Raviele
    • 1
  • S. Themistoclakis
    • 1
  • Italian Endotak Investigator Group
    • 1
  1. 1.Divisione di CardiologiaOspedale Umberto IMestre-VeniceItaly

Personalised recommendations